At BalanX Bio, I conduct literature reviews and extract findings on biomarker and microbiome research. I also maintain a structured project database that supports research reuse and traceability.
For my Cancer Driver Explorer project, I analyzed 3.6 million somatic mutations across 585 TCGA-LUAD patients. I used nucleotide-context normalization to distinguish potential drivers from large-gene artifacts, flagging TTN as a false-positive top hit.
At Northeastern University’s Antimicrobial Discovery Center, I wrote a Python script to retrieve 16S rRNA sequences from NCBI and collected about 2,000 sequences for phylogenetic analysis. I aligned the sequences and constructed a phylogenetic tree to study antimicrobial resistance mechanisms and support compound identification.
My research has also included a GWAS on cancer-associated variants at StemCyte India Therapeutics Pvt. Ltd. and an end-to-end variant-calling pipeline at Rapture Biotech. I’ve applied RNA-seq and single-cell methods across projects, including a bulk RNA-seq pipeline that identified 823 significant differentially expressed genes.

